Repression by sustained‐release β‐glucuronidase inhibitors of chemical carcinogen‐mediated induction of a marker oncofetal protein in rodents
- 31 December 1987
- journal article
- research article
- Published by Taylor & Francis in Journal of Toxicology and Environmental Health
- Vol. 23 (1) , 15-27
- https://doi.org/10.1080/15287398809531093
Abstract
The degree of induction of an oncofetal protein marker in rodents by selected chemical carcinogens has been correlated with changes in carcinogenicity induced by dietary D‐glucaro‐1,4‐lactone (GL) based anticarcinogens. These potent anticarcinogens may act to increase the clearance of carcinogens as glucuronides through the inhibition of β‐glucuronidase. The sustained‐release forms are particularly effective, 7.5 mmol/kg of GL maintaining serum β‐glucuronidase activity at or below 50% for only 1 h, while an equivalent amount of calcium glucarate (CCT) maintained this level of inhibition for over 5 h. CCT or other sustained‐release inhibitors, when fed to rodents during administration of carcinogens that undergo glucuronidation, caused a marked reduction in the induction of the marker protein. For those systems where other markers of carcinogenesis were also assessed, it was determined that the inhibition of marker‐protein induction was quantitatively similar to both the inhibition of binding of the carcinogen to DNA and the subsequent induction of tumors in target organs.Keywords
This publication has 32 references indexed in Scilit:
- Chemical carcinogens as specific inducers of a 60-kilodalton oncofetal protein in ratsCarcinogenesis: Integrative Cancer Research, 1985
- Immunological identity of a 60 KD oncofetal protein induced in rats by chemical carcinogens and released by transformed cellsBiochemical and Biophysical Research Communications, 1985
- Comparison of the in vitro and in vivo hepatic metabolism of the carcinogen 1-nitropyreneCarcinogenesis: Integrative Cancer Research, 1985
- Nucleocytoplasmic release of repetitive DNA transcripts in carcinogenesis correlates with a 60 kilodalton cytoplasmic proteinCancer Letters, 1984
- Metabolism of 1-nitro[14C]pyrene in vivo in the rat and mutagenicity of urinary metabolitesCarcinogenesis: Integrative Cancer Research, 1984
- Tumorigenicity and metabolism of 1-nitropyrene in A/J miceCarcinogenesis: Integrative Cancer Research, 1984
- Conformations of the d-glucarolactones and d-glucaric acid in solutionCarbohydrate Research, 1982
- The biliary excretion and enterohepatic circulation of benzo (a)pyrene and its metabolites in the ratBiochemical Pharmacology, 1981
- 2, 5-DI-O-ACETYL-D-GLUCOSACCHARO-(1→4), (6→3)-DILACTONE, A NEW POTENT β-GLUCURONIDASE INHIBITORThe Japanese Journal of Pharmacology, 1965
- Enzyme Activity in Relation to CancerBritish Journal of Cancer, 1957